In vivo vascular effects of genistein on a rat model of septic shock induced by lipopolysaccharide

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 3, 2003, Pages 329-338

  Bermejo, Almudena ^a   Zarzuelo, Antonio ^a   Duarte, Juan ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Genistein; Lipopolysaccharide; Nitric oxide synthase; Tyrosine kinase inhibitors; Vascular smooth muscle

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; ARGININE; DAIDZEIN; ENDOTOXIN; GENISTEIN; LIPOPOLYSACCHARIDE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRITE; NORADRENALIN; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR MALFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HYPOTENSION; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

ACETYLCHOLINE; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PRESSURE; DRUG INTERACTIONS; GENISTEIN; HYPOTENSION; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; SHOCK, SEPTIC;

EID: 0041837596     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200309000-00003     Document Type: Article

References (42)

1. Rangel-Frausto MS. The epidemiology of bacterial sepsis. Infect Dis Clin North Am. 1999;13:299-312.
2. Shenep JL. Septic shock. Adv Pediatr Infect Dis. 1997;12:209-241.
3. Groeneveld AB, Natua JJ, Thijs LG. Peripheral vascular resistance in septic shock, Its relation to outcome. Intensive Care Med. 1988;14:141-147.
4. Marczin N, Papapetropoulos A, Jilling T, et al. Prevention of nitric oxide synthase induction in vascular smooth muscle cells by microtubule depolymerizing agents. Br J Pharmacol. 1993;109:603-605.
5. Fleming I, Gray GA, Julou-Schaeffer G, et al. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun. 1990;171:562-568.
6. Szabo C, Mitchell JA, Thiemerrnann C, et al. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol. 1993;108:786-792.
7. Moritoki H, Hisayama T, Takeuchi S, et al. Possible involvement of tyrosine kinase in the LPS-promoted initiation of L-arginine-induced relaxation of rat aorta mediated by induction of NO synthase. Life Sci. 1995;57:125-130.
8. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci. 1992;17:399-402.
9. G-monomethyl-L-arginine or indomethacin. J Pharmacol Exp Ther. 1995;272:452-459.
10. Kirkeboen KA, Strand OA. The role of nitric oxide in sepsis - an overview. Acta Anaesthesiol Scand. 1999;43:275-288.
11. Wu CC, Ruetten H, Thiemermann C. Comparison of the effects of aminoguanidine and N-omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxemia in the rat. Eur J Pharmacol. 1996;300:99-104.
12. Akarasereenont P, Mitchell JA, Appleton I, et al. Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cell. Br J Pharmacol. 1994;113:1522-1528.
13. Yang ZG, Bochler PN, Carroll RC, et al. Signal-transduction pathway of bacterial lipopolysaccharide-stimulated bovine vascular endothelial-cells. Inflammation. 1994;18:221-223.
14. Geng Y, Maier R, Lotz M. Tyrosine kinases are involved with the expression of inducible nitric oxide synthase in human articular chondrocytes. J Cell Physiol. 1995;163:545-554.
15. Duarte J, Ocete MA, Pérez-Vizcaíno F, et al. Effects of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase. Eur J Pharmacol. 1997;338:25-33.
16. Ruetten H, Thiemerrnann C. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat, a possible role for protein tyrosine kinase. Br J Pharmacol. 1997;122:59-70.
17. McGregor DD. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol. 1965;177:21-30.
18. Grisham MB, Johnson GG, Gautreaux MD, et al. Measurement of nitrate and nitrite in extracellular fluids, a window to systemic nitric oxide metabolism. Meth Enzymol. 1995;7:84-90.
19. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products, Malonaldehyde and 4-hydroxylnonenal. Meth Enzymol. 1990;113:548-555.
20. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85.
21. Fink MP, Homer LD, Fletcher JR. Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats, Evidence for a prostaglandin-mediated effect. J Surg Res. 1985;38:335-342.
22. Mitolo-Chieppa D, Serio M, Potenza MA, et al. Hyporeactivity of mesenteric vascular bed in endotoxin-treated rats. Eur J Pharmacol. 1996;309:175-182.
23. Boyle WA, Parvathaneni LS, Bourlier V, et al. iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ Res. 2000;87:E18-E24.
24. Fatehi-Hassanabad Z, Furman BL, Parratt JR. Effect endotoxin on sympathetic responses in the rat isolated perfused mesenteric bed; involvement of nitric oxide and cyclo-oxygenase products. Br J Pharmacol. 1995;116:3316-3322.
25. Mitchell JA, Kohlhaas KL, Sorrentino R, et al. Induction by endotoxin of nitric oxide synthase in the rat mesentery, lack of effect on action of vasoconstrictors. Br J Pharmacol. 1993;109:265-270.
26. Martinez MC, Muller B, Stoclet JC, et al. Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery. Br J Pharmacol. 1996;118:1218-1222.
27. Fleming I, Gray GA, Stoclet JC. Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas. Am J Physiol. 1993;264: H1200-H1207.
28. Smith REA, Palmer RMJ, Moncada S. Coronary vasodilatation induced by endotoxin in the rabbit isolated perfused heart is nitric oxide-dependent and inhibited by dexamethasone. Br J Pharmacol. 1991;104:5-6.
29. Herrera MD, Zarzuelo A, Jiménez J, et al. Effects of flavonoids on rat aortic smooth muscle contractility, structure-activity relationships. Gen Pharmacol. 1996;27:273-277.
30. 2+ entry is inhibited by the tyrosine kinase inhibitor genistein in fura-2-loaded human platelets. J Physiol. 1993;459:292P.
31. Ozaki Y, Yatomi Y, Jinnai Y, et al. Effects of genistein, a tyrosine kinase inhibitor on platelet function. Biochem Pharmacol. 1993;46:395-403.
32. Novogrodsky A, Vanichkin A, Patya M, et al. Prevention of lipopolysaccharide induced lethal toxicity by tyrosine kinase inhibitors. Science. 1994;264:1319-1322.
33. MacArthur H, Westfall TC, Riley DP, et al. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A. 2000;97:9753-9758.
34. Hecker M, Preß C, Schini-Kerth VB, et al. Antioxidants differentially affect nuclear factor κB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett. 1996;380:224-228.
35. Brandes RP, Koddenberg G, Gwinner W, et al. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension. 1999;33:1243-1249.
36. Szabo C, Cuzzocrea S, Zingarelli B, et al. Endothelial dysfunction in a rat model of endotoxic shock, importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J Clin Invest. 1997;100:723-735.
37. Pasquet JP, Zou MH, Ullrich V. Peroxynitrite inhibition of nitric oxide synthases. Biochimie. 1996;78:785-791.
38. Ravichandran LV, Johns RA, Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol. 1995;268:H2216-H2223.
39. Honore EK, Williams JK, Anthony MS, et al. Soy protein isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril. 1997;67:148-154.
40. Karamsetty MR, Klinger JR, Hill NS. Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats. J Pharmacol Exp Ther. 2001;297:968-974.
41. Squadrito F, Altavilla D, Squadrito G, et al. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res. 2000;45:454-462.
42. Wei H, Bowen R, Cai Q, et al. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med. 1995;208:124-130.